Adalimumab/infliximab: Worsening of (or de novo) psoriasis: 5 case reports

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1233, 2009-01, pp. : 4-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab/infliximab: Psoriasis: 4 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. : 4-5

Adis International

Access to resources Recommend Favorite

Adalimumab/infliximab: Psoriasis: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1128, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Adalimumab/infliximab: Tuberculosis flare: 5 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Adalimumab/infliximab: Histoplasmosis: 5 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1336, 2011-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Adalimumab/efalizumab/infliximab: Psoriasis: 5 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite